Browsing Tag
Citizens JMP
2 posts
Rhythm Pharmaceuticals (RYTM) TRANSCEND trial in NEJM shows 19.8% placebo-adjusted BMI reduction
Rhythm Pharma (RYTM) TRANSCEND Phase 3 published in NEJM validates IMCIVREE for acquired hypothalamic obesity. 10,000-patient US market launch trajectory ahead.
From launch to constellation: how Rocket Lab’s $8bn Iridium deal closes the loop
Rocket Lab (RKLB) to acquire Iridium (IRDM) in $8B cash-stock deal, creating a vertically integrated space platform. Full analysis from BNT on the SpaceX challenger.